Trial Profile
pH-weighted MRI in Multiple Sclerosis: A Surrogate Marker of Tissue Metabolic Stress
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Gadobutrol (Primary)
- Indications Multiple sclerosis
- Focus Diagnostic use
- 03 Oct 2019 Status changed from recruiting to completed.
- 19 Oct 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
- 01 Feb 2018 Planned End Date changed from 1 Jan 2019 to 1 Jun 2019.